| Serial Number | 79069710 |
| Word Mark | PHARMTRACE |
| Filing Date | Wednesday, February 11, 2009 |
| Status | 706 - SECTION 71 ACCEPTED |
| Status Date | Tuesday, September 1, 2020 |
| Registration Number | 3799744 |
| Registration Date | Tuesday, June 8, 2010 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 23, 2010 |
| Goods and Services | [ Education services, namely, providing classes, seminars, workshops and training in the fields of drug development, life cycle management, clinical research and development,diagnostic imaging and molecular medicine; provision of training, namely, subject-specific further training in the field of clinical research and development, diagnostic imaging and molecular medicine; organization and arranging of seminars; entertainment, namely,organization of exhibitions for cultural or educational purposes and organizing community sporting and cultural events ] |
| Pseudo Mark | PHARMACEUTICAL TRACE |
| Goods and Services | [ Advertising and advertisement services; marketing services regarding clinical trials, namely, business consulting services with respect to marketing clinical trials; providing advertising, marketing and promotional services for the pharmaceutical and medical products of others, namely, marketing services regarding pharmaceutical products by means of promoting clinical trial data, including diagnostic imaging procedures; business management; business administration; providing office functions ] |
| Goods and Services | [ Medical and veterinary services; hygienic and beauty care for human beings and animals; advisory services relating to pharmaceutical preparations ] |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, scientific research and development, and providing medical and scientific research information in the fields of pharmaceuticals, clinical trials, drug development, life cycle management, clinical research and development, diagnostic imaging and molecular medicine; industrial analysis and research services in the fields of pharmaceuticals, clinical trials, drug development, life cycle management, clinical research and development, diagnostic imaging and molecular medicine; design and development of computer hardware and software |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, January 27, 2017 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, January 27, 2017 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 10, 2009 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Friday, January 27, 2017 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pharmtrace klinische Entwicklung GmbH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Berlin 10117 DE |
| Party Name | Pharmtrace klinische Entwicklung GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Berlin 10117 DE |
| Party Name | Pharmtrace klinische Entwicklung GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Berlin 10117 DE |
| Event Date | Event Description |
| Monday, March 20, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, December 9, 2022 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| Wednesday, December 7, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
| Wednesday, December 7, 2022 | GENERIC MADRID TRANSACTION CREATED |
| Saturday, May 1, 2021 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Saturday, January 23, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, December 19, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, September 1, 2020 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Tuesday, September 1, 2020 | REGISTERED-SEC.71 ACCEPTED |
| Tuesday, September 1, 2020 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, June 4, 2020 | TEAS SECTION 71 RECEIVED |
| Tuesday, May 12, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, May 12, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, May 12, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 12, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 12, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, August 23, 2019 | INTERNATIONAL REGISTRATION RENEWED |
| Thursday, July 18, 2019 | REFUSAL PROCESSED BY IB |
| Saturday, June 8, 2019 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED |
| Thursday, December 28, 2017 | PARTIAL INVALIDATION PROCESSED BY THE IB |
| Thursday, September 28, 2017 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Thursday, September 28, 2017 | INVALIDATION PROCESSED |
| Wednesday, September 27, 2017 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Saturday, January 28, 2017 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
| Friday, January 27, 2017 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
| Thursday, January 19, 2017 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Tuesday, January 10, 2017 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Wednesday, July 13, 2016 | POST REGISTRATION ACTION MAILED - SEC.71 |
| Monday, July 11, 2016 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, June 3, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 3, 2016 | TEAS SECTION 71 RECEIVED |
| Tuesday, February 12, 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, September 9, 2010 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, September 9, 2010 | FINAL DISPOSITION PROCESSED |
| Wednesday, September 8, 2010 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, June 8, 2010 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 23, 2010 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 3, 2010 | NOTICE OF PUBLICATION |
| Wednesday, February 17, 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, February 17, 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 20, 2010 | AMENDMENT FROM APPLICANT ENTERED |
| Wednesday, January 20, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 20, 2010 | ASSIGNED TO LIE |
| Tuesday, January 12, 2010 | PAPER RECEIVED |
| Saturday, September 19, 2009 | REFUSAL PROCESSED BY IB |
| Wednesday, July 15, 2009 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, July 15, 2009 | REFUSAL PROCESSED BY MPU |
| Wednesday, July 15, 2009 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, July 14, 2009 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 14, 2009 | APPLICATION FILING RECEIPT MAILED |
| Friday, July 10, 2009 | ASSIGNED TO EXAMINER |
| Friday, July 10, 2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 9, 2009 | SN ASSIGNED FOR SECT 66A APPL FROM IB |